Evidence map›Paper›PMID 32162203›Full record

ArticleJournal of general internal medicine2020

Psychometric Properties of the Altarum Consumer Engagement (ACE) Measure of Activation in Patients with Prediabetes.

Yelba Castellon-Lopez, Kia Skrine Jeffers, O Kenrik Duru, Gerardo Moreno, Tannaz Moin, Jonathan Grotts, Carol M Mangione, Keith C Norris, Ron D Hays

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Psychometric evaluation of a patient-reported item bank for healthcare engagement.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yelba Castellon-LopezDepartment of Family Medicine, University of California Los Angeles, 10880 Wilshire Blvd, Suite 1800, Los Angeles, CA, 90095, USA. ycastellon@mednet.ucla.edu.ORCID 0000-0002-4886-7792
Kia Skrine JeffersUCLA School of Nursing, Los Angeles, CA, USA.
O Kenrik DuruDepartment of Medicine, Division of General Internal Medicine-Health Services Research, University of California, Los Angeles, CA, USA.
Gerardo MorenoDepartment of Family Medicine, University of California Los Angeles, 10880 Wilshire Blvd, Suite 1800, Los Angeles, CA, 90095, USA.
Tannaz MoinDepartment of Medicine, Division of General Internal Medicine-Health Services Research, University of California, Los Angeles, CA, USA.
Jonathan GrottsDepartment of Medicine, Division of General Internal Medicine-Health Services Research, University of California, Los Angeles, CA, USA.
Carol M MangioneDepartment of Medicine, Division of General Internal Medicine-Health Services Research, University of California, Los Angeles, CA, USA.
Keith C NorrisDepartment of Medicine, Division of General Internal Medicine-Health Services Research, University of California, Los Angeles, CA, USA.
Ron D HaysDepartment of Medicine, Division of General Internal Medicine-Health Services Research, University of California, Los Angeles, CA, USA.
Los Angeles County Department of Health Services · USUniversity of California, Los Angeles · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CATHERINE A SARKISIAN · 2002 to 2026
$19.7M
NRSA Training CoreTL1TR001883 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEX BUI, Nina Thawata Harawa · 2016 to 2026
$8.6M
A Cluster-Randomized Trial of Pharmacist-Coordinated Implementation of the DPPR18DK105464 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DURU, OBIDIUGWU KENRIK, MANGIONE, CAROL M · 2015 to 2019
$3.3M
Health IT decision support to improve medication management safety and qualityK23AG042961 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORENO, GERARDO · 2012 to 2016
$699k
NCATS NIH HHS TL1 TR001883NCATS NIH HHS UL1 TR001881NIA NIH HHS K23 AG042961NIA NIH HHS P30 AG021684NIDDK NIH HHS 5R18-DK105464-04NIDDK NIH HHS R18 DK105464NIH HHS P30-AG021684NIH HHS UL1TR001881
6 · The paper itself

Abstract

backgroundPatient activation is associated with better outcomes in chronic conditions.

objectiveWe evaluated the psychometric properties of the 12-item Altarum Consumer Engagement™ Measure (ACE-12) in patients with prediabetes.

participantsACE-12 was administered to patients in the Prediabetes Informed Decisions and Education Study. MAIN MEASURES: We conducted an exploratory factor analysis followed by confirmatory factor analytic models. We evaluated item response categories using item characteristic curves. Construct validity was assessed by examining correlations of the ACE-12 scales with education, depressive symptoms, self-rated health, hemoglobin A1c, body mass index, and weight loss. KEY

resultsParticipants (n = 515) had a median age of 58; 56% were female; 17% Hispanic; 54% were non-White. The scree plot and Tucker and Lewis reliability coefficient (0.95) suggested three factors similar to the original scales. One item loaded on the navigation rather than the informed choice scale. Ordinal alpha coefficients for the original scales were commitment (0.75); informed choice (0.71); and navigation (0.54). ICCs indicated that one or more of the response categories for 5 of the 12 items were never most likely to be selected. Patients with lower education were less activated on the commitment (r = - 0.124, p = 0.004), choice (r = - 0.085, p = 0.009), and overall score (r = - 0.042, p = 0.011). Patients with depressive symptoms had lower commitment (r = - 0.313, p ≤ 0.001) and overall scores (r = - 0.172, p = 0.012). Patients with poorer health scored lower on the Commitment (r = - 0.308, p ≤ 0.001), Navigation (r = - 0.137, p ≤ 0.001), and overall score (r = - 0.279, p ≤ 0.001).

conclusionThe analyses provide some support for the psychometric properties of the ACE-12 in prediabetic patients. Future research evaluating this tool among patients with other chronic conditions are needed to determine whether Q1 (I spend a lot of time learning about health) should remain in the informed choice or be included in the navigation scale. Additional items may be needed to yield acceptable reliability for the navigation scale.

Indexed as

Prediabetic StateFemaleHumansMalePatient ParticipationPsychometricsReproducibility of ResultsSurveys and Questionnairespatient activationprediabetespsychometric

Identifiers

PMID32162203
PMCPMC7661602
OpenAlexW3012150776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.